These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31385434)

  • 1. Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma.
    Di Carlo D; Ferrari A; Toffolutti T; Milano GM; Manzitti C; Ruggiero A; Dall'Igna P; Melchionda F; Zanetti I; Scarzello G; Bisogno G
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27932. PubMed ID: 31385434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
    Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups.
    Minard-Colin V; Walterhouse D; Bisogno G; Martelli H; Anderson J; Rodeberg DA; Ferrari A; Jenney M; Wolden S; De Salvo G; Arndt C; Merks JHM; Gallego S; Schwob D; Haie-Meder C; Bergeron C; Stevens MCG; Oberlin O; Hawkins D;
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27096. PubMed ID: 29781567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival for children with parameningeal rhabdomyosarcoma: results from the AIEOP soft tissue sarcoma committee.
    Bisogno G; De Rossi C; Gamboa Y; Sotti G; Ferrari A; Dallorso S; Donfrancesco A; Cecchetto G; Calderone M; Gandola L; Rosolen A; Carli M
    Pediatr Blood Cancer; 2008 Jun; 50(6):1154-8. PubMed ID: 18300319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.
    Bisogno G; Compostella A; Ferrari A; Pastore G; Cecchetto G; Garaventa A; Indolfi P; De Sio L; Carli M
    Cancer; 2012 Feb; 118(3):821-7. PubMed ID: 21751206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in children undergoing salvage surgery for bladder/prostate rhabdomyosarcoma.
    Angelini L; Bisogno G; Alaggio R; Scarzello G; Santoro L; Zanetti I; Scagnellato A; Basso E; D'Angelo P; Ferrari A; Castagnetti M
    J Pediatr Urol; 2016 Aug; 12(4):265.e1-8. PubMed ID: 27255731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
    Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
    J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
    Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
    J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the prognosis of 111 patients with gastric cancer or adenocarcinoma of the esophagogastric junction combined with pleural or abdominal effusion].
    Liu Y; Du CX; Zhang HG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):693-7. PubMed ID: 24332058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group.
    Ferrari A; Casanova M; Bisogno G; Zanetti I; Cecchetto G; De Bernardi B; Riccardi R; Tamaro P; Meazza C; Alaggio R; Ninfo V; Carli M;
    Cancer; 2003 May; 97(10):2597-604. PubMed ID: 12733159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
    Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
    J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Joshi D; Anderson JR; Paidas C; Breneman J; Parham DM; Crist W;
    Pediatr Blood Cancer; 2004 Jan; 42(1):64-73. PubMed ID: 14752797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
    Liu YT; Wang CW; Hong RL; Kuo SH
    Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites, pleural, and pericardial effusions in acute pancreatitis. A prospective study of incidence, natural history, and prognostic role.
    Maringhini A; Ciambra M; Patti R; Randazzo MA; Dardanoni G; Mancuso L; Termini A; Pagliaro L
    Dig Dis Sci; 1996 May; 41(5):848-52. PubMed ID: 8625753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.
    Minn AY; Lyden ER; Anderson JR; Million L; Arndt CA; Brown K; Hawkins DS; Donaldson SS
    J Clin Oncol; 2010 Sep; 28(27):4228-32. PubMed ID: 20713850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.